Another more recent study with a larger number of patients also explored this “combined therapy” with a TPO-RA (romiplostim or eltrombopag) plus immunosuppressant therapy (MMF, azathioprine, cyclophosphamide, CsA, or everolimus) in 39 adults with refractory ITP. Here, TPO is linked to rheumatoid arthritis.